DR. REDDY S LABORATORIES
NSE₹1,205.20·DRREDDY·INE089A01031
Previous session · source 2026-09-19SnapshotPrice chart
fast lightweight viewDRREDDY 1M line chart. 14 bars, from 1,154.4 to 1,185, up 2.65 percent.
Market depth
live order bookBuy orders68.99%Sell orders31.01%
| Bid Price | Qty | Ask Price | Qty |
|---|---|---|---|
| 1,186.10NSE | 197 | 1,186.20NSE | 330 |
| 1,186.00BSE | 10 | 1,186.30NSE | 388 |
| 1,186.00NSE | 1,734 | 1,186.40NSE | 116 |
| 1,185.95BSE | 15 | 1,186.70NSE | 79 |
| 1,185.90NSE | 107 | 1,186.80NSE | 48 |
| 1,185.85BSE | 276 | 1,187.05BSE | 29 |
| 1,185.80BSE | 147 | 1,187.10BSE | 8 |
| 1,185.75BSE | 46 | 1,187.30BSE | 21 |
| 1,185.70NSE | 142 | 1,187.55BSE | 21 |
| 1,185.60NSE | 500 | 1,187.65BSE | 387 |
| Bid Total | 3,174 | Ask Total | 1,427 |
- 1,182.60
- Open
- 1,207.50
- High
- 1,182.10
- Low
- 1,205.20
- Close
Performance
Today’s lowToday’s high
₹1,182.10₹1,207.50
52-week low52-week high
₹1,130.00₹1,207.50
Open₹1,182.60
Prev close₹1,205.20
Volume23.49 L
Latest dividend₹8 · 10 Jul 26
Investor snapshot
fast read from available feedsPrice positionRange unavailableQuote unavailable
Profitability14%Latest ROCE
Growth+3.23%Revenue YoY, latest annual
Ownership26.6% promoterLatest shareholding
DerivativesF&O availableOption chain linked
Use this as a navigation aid. It summarizes feed observations, not a buy or sell view.
Financials
₹ croreRevenue and profit growth
latest Mar 2026Revenue growth
1Y+3.23%
3Y CAGR+10.96%
Net profit growth
1Y−27.37%
3Y CAGR−2.65%
Historical returns
computed from available OHLC1DNot available
1W+1.67%
1M+2.65%
3M+2.65%
6M+2.65%
1Y+2.65%
Company profile
Large cap company in Pharmaceuticals, part of the Healthcare sector.
SectorHealthcare
IndustryPharmaceuticals
Listed{'exchange': 'NSE', 'symbol': 'DRREDDY', 'status': 'Listed'}
Founded1984
HeadquartersHyderabad, India
ISININE089A01031
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company engaged in the manufacture and marketing of pharmaceutical products. Its business includes global generics, pharmaceutical services and active ingredients (API), and other research-linked operations. The company serves markets in India and internationally.
- Listed on NSE under the symbol DRREDDY.
- Core segments include Global Generics and Pharmaceutical Services and Active Ingredients (PSAI).
- Operates as an integrated pharmaceutical company with a presence in India and overseas markets.
- Headquartered in Hyderabad, India.